Xiaohui Lu

Xiaohui Lu has extensive experience in analytical development within the pharmaceutical industry, currently serving as Executive Director of Analytical Development at Ultragenyx Pharmaceutical Inc. Previously, Xiaohui held leadership roles at CRISPR Therapeutics and Biogen, progressing from Director to Senior Scientist roles. Prior experience includes a Senior Research Scientist position at ARIAD Pharmaceuticals and a Postdoctoral role at the Whitehead Institute. Xiaohui Lu earned a Ph.D. in Biochemistry from the Geisel School of Medicine at Dartmouth and also holds a degree from Wuhan University.